p300 Modulates the BRCA1 inhibition of estrogen receptor activity - Test2 - elhamkhani - TriplyDB

p300 Modulates the BRCA1 inhibition of estrogen receptor activity

p300 Modulates the BRCA1 inhibition of estrogen receptor activity

http://www.wikidata.org/entity/Q28215039

about

sameAs

Transcriptional regulation of BRCA1 expression by a metabolic switch The roles of sex steroid receptor coregulators in cancer BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact?Protein lysine acetylation by p300/CBP BRCA1 and Oxidative Stress Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers The C/H3 domain of p300 is required to protect VRK1 and VRK2 from their downregulation induced by p53 BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha.The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.New roles of cyclin D1.Estrogen receptor coregulators and pioneer factors: the orchestrators of mammary gland cell fate and development.New role for nuclear hormone receptors and coactivators in regulation of BRCA1-mediated DNA repair in breast cancer cell lines.Regulated recruitment of tumor suppressor BRCA1 to the p21 gene by coactivator methylation.High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma Decreased progesterone receptor isoform expression in luteal phase fallopian tube epithelium and high-grade serous carcinoma Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer.Regulation of progesterone receptor signaling by BRCA1 in mammary cancer.p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape.Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models.DNA stabilization by the upregulation of estrogen signaling in BRCA gene mutation carriers.Immunohistochemical evaluation of ROCK activation in invasive breast cancer BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like site High expression of p300 is linked to aggressive features and poor prognosis of nasopharyngeal carcinoma.BRCA1 deficient mouse models to study pathogenesis and therapy of triple negative breast cancer.Derailed estrogen signaling and breast cancer: an authentic couple.High Expression of p300 in Human Breast Cancer Correlates with Tumor Recurrence and Predicts Adverse Prognosis.BRCA1, hormone, and tissue-specific tumor suppression Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression.Modulation of p300/CBP Acetylation of Nucleosomes by Bromodomain Ligand I-CBP112.Differential effects of HTLV-1 Tax oncoprotein on the different estrogen-induced-ER α-mediated transcriptional activities.Abnormal Mammary Adipose Tissue Environment of Brca1 Mutant Mice Show a Persistent Deposition of Highly Vascularized Multilocular Adipocytes.The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.Validation of transgenic models of breast cancer: ductal carcinoma in situ (DCIS) and Brca1-mutation-related breast cancer.Profiling of Cross-Functional Peptidases Regulated Circulating Peptides in BRCA1 Mutant Breast Cancer.Beta protein 1 homeoprotein induces cell growth and estrogen-independent tumorigenesis by binding to the estrogen receptor in breast cancer.Sanguinarine is a novel VEGF inhibitor involved in the suppression of angiogenesis and cell migration.Estrogen receptor alpha represses transcription of early target genes via p300 and CtBP1 Acetylation at lysine 183 of progesterone receptor by p300 accelerates DNA binding kinetics and transactivation of direct target genes.The Effect of Reproductive Factors on Breast Cancer Presentation in Women Who Are BRCA Mutation Carrier.

P2860

Q24307973-B8136CC7-A7A6-4994-A969-6817495518E1 Q24799904-399DDC92-B115-4AA6-B298-3A53C3230AE6 Q26822737-F4F3AB2A-CC05-4A1D-9EE1-45D5CC3E9DF1 Q27021749-E122B1A5-71B4-4926-BF58-DBE4EE151667 Q28388921-8C4DA81D-10FD-48BE-9213-387D1D9A93DD Q30439093-D4D793C4-4395-4342-9D73-2A85EFAF3A8D Q33327785-BA7B947B-8167-4E6F-8F44-4270CA3E7993 Q33350162-548E81CA-1841-4621-B986-42D587E73463 Q33576505-2A2D2013-BA33-4218-BBF6-4F04BD34E437 Q33652431-F1F1BDB4-B088-47BF-B34E-1073337A6D93 Q34352513-EB48B670-538D-48A5-9EC5-0A377C0EC56C Q34391427-3E45E9FA-DEB5-45B1-82D7-96691C9ACA2B Q34480612-FF7CB704-1FE9-4F5E-9B79-1EAAFA43A8B8 Q34497338-6EA17BE7-42C9-4C79-826D-B879481AD904 Q34499336-E1E0ACAD-D870-48D9-A01A-B06A1B52479E Q34595670-42B5F0DB-4ACE-45E5-8CB0-ADD232ABFF85 Q34609774-DD18EE61-4273-48F5-B5C5-B78BD2395D55 Q34652156-A8085FA6-3B51-4D05-930C-C7A866541976 Q34997026-872F882C-BD18-4AF3-B78C-E9B5925F0B84 Q35157919-AE348F9D-4740-4409-8D5B-605788DB9E0C Q35633272-AF9A283A-3B90-4F87-8DD5-EBA119045697 Q35857568-8503D4EA-87D8-4F62-B45B-470A2930CE74 Q36072014-5ACA0ED4-45C4-43E3-B0C3-4789EBA63FD9 Q36356267-63675AC9-4F2D-40B2-B902-8246B125C8F0 Q36406519-C672034D-179E-4767-BC7E-C4CD77781349 Q36589361-CD2DFD3D-CE95-4000-BF4C-02B21068BE0E Q36654710-17CD77F1-DCFB-4F94-9DDB-B3FEC81FEB1F Q37020551-6AE59779-6A9A-4FA8-9130-626C70CBA18C Q37102942-5950F1E2-CA29-4079-B89B-A2BDCB2156C2 Q37223691-CDBFEC6E-D3A2-4C45-A07B-3F10EF97FDFF Q37317061-49F2D49C-A99B-44B7-9FCC-84AF25FA61CE Q37364047-370555F1-D07B-40E7-A69D-6F980BA4FAF7 Q37395245-EE351578-22A5-48D4-863B-F9058E36D9A5 Q37412593-F509CA41-3D9E-4F4D-AE9E-20BD5DDB9933 Q37443351-24174189-4EF3-4962-95CC-D0F690747182 Q37619725-A18858F4-87E7-4C35-AF85-67D4FF8A1244 Q38292799-20A89ADB-7874-498A-9B4F-A7CEE94C5398 Q39888245-6724C4B8-BAED-41B6-9621-4C6059C8ABD7 Q41889260-C1C509FC-2E87-45FB-8E43-237EA473144B Q42108162-B459E5C6-6819-4C3B-B017-825C1878B410

P2860

p300 Modulates the BRCA1 inhibition of estrogen receptor activity

http://www.wikidata.org/entity/Q28215039

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

p300 Modulates the BRCA1 inhibition of estrogen receptor activity

@ast

p300 Modulates the BRCA1 inhibition of estrogen receptor activity

@en

p300 Modulates the BRCA1 inhibition of estrogen receptor activity

@nl

type

label

p300 Modulates the BRCA1 inhibition of estrogen receptor activity

@ast

p300 Modulates the BRCA1 inhibition of estrogen receptor activity

@en

p300 Modulates the BRCA1 inhibition of estrogen receptor activity

@nl

prefLabel

p300 Modulates the BRCA1 inhibition of estrogen receptor activity

@ast

p300 Modulates the BRCA1 inhibition of estrogen receptor activity

@en

p300 Modulates the BRCA1 inhibition of estrogen receptor activity

@nl

P1433

Q28215039-1A9BFB03-7613-4E76-9C1E-442E866D30E4

P1476

Q28215039-DEE563CD-C586-4BCC-A742-C69D285A13D5

P2093

Q28215039-186C8445-6FED-4874-9E67-D7355CE0F0B5

Q28215039-1A84B54B-8ECF-4EC6-AEFB-00FC7BED86E2

Q28215039-2F4BFD86-A034-41BC-BB13-B91AC2575298

Q28215039-3155919E-0570-45E6-A544-241C250D1632

Q28215039-51D1E8DD-F2F0-49BC-B1BD-821FBD9C083E

Q28215039-595B9C11-A089-45D1-9C3D-6DB026C4FB4F

Q28215039-7AC593A9-CF98-4D6E-B81C-C5B69B6070B6

Q28215039-83273972-4A99-4002-9EA3-B88255FC5904

Q28215039-AD10E12A-B56D-4AD0-B542-35AC36C44BB8

Q28215039-AF59EF34-682C-449C-AB5D-E0C02BB3D42A

P304

Q28215039-D910E0AD-7330-49E7-872E-5E005E341386

P31

Q28215039-970E9311-F9D6-43A1-A297-A184FEFDABFB

P407

Q28215039-14C6C52E-8461-48CA-AD8B-0A20EE9C28AD

P433

Q28215039-790FCD12-4E7E-4D8F-A21D-463C69D681D6

P478

Q28215039-D0B4EFF6-453B-4CE6-92B2-D5D502C6013C

P577

Q28215039-7808EA42-D62D-4CF5-893B-209D1EA6C784

P698

Q28215039-13929675-4CE4-4015-9ABA-CCEBE660FC71

P1433

Cancer Research

P1476

p300 Modulates the BRCA1 inhibition of estrogen receptor activity

@en

P2093

Chenguang Wang

http://www.w3.org/2001/XMLSchema#string

Eliot M Rosen

http://www.w3.org/2001/XMLSchema#string

Itzhak D Goldberg

http://www.w3.org/2001/XMLSchema#string

Ji-An Wang

http://www.w3.org/2001/XMLSchema#string

Michael Erdos

http://www.w3.org/2001/XMLSchema#string

Paul Webb

http://www.w3.org/2001/XMLSchema#string

Peter J Kushner

http://www.w3.org/2001/XMLSchema#string

Qinghui Meng

http://www.w3.org/2001/XMLSchema#string

Ren-Qi Yuan

http://www.w3.org/2001/XMLSchema#string

Richard G Pestell

http://www.w3.org/2001/XMLSchema#string

P304

141-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11782371

http://www.w3.org/2001/XMLSchema#string